MM

Marc Mesick

Professional Summary



Professional Overview


Marc Mesick is an experienced finance executive currently serving as the Vice President - Finance / Chief Financial Officer at Ellis Medicine in Schenectady, New York. With a strong background in financial management, strategic planning, and operational oversight, he plays a key role in guiding the financial strategy and performance of this leading healthcare organization.

Experience Summary



Current Role


As Vice President - Finance / Chief Financial Officer at Ellis Medicine, Marc is responsible for overseeing all financial operations, including budgeting, forecasting, and financial reporting. He works closely with the executive team to develop and implement financial strategies that support the organization's growth and operational efficiency. Under his leadership, Ellis Medicine has achieved significant improvements in financial performance and process optimization.

Career Progression


Prior to his current role, Marc served as the Director of Finance at Ellis Medicine, where he was instrumental in enhancing the organization's financial reporting and implementing cost-saving measures. Before joining Ellis Medicine, he spent over 15 years as a Principal at UHY LLP, a leading accounting and advisory firm, where he provided strategic financial guidance to a diverse range of clients across various industries.

Academic Background


Marc holds a Bachelor's degree in Accounting from the State University of New York at Albany, where he graduated with distinction. He is a Certified Public Accountant (CPA) and has a strong track record of continuing professional development to stay abreast of industry trends and best practices.

Areas of Expertise


  • Financial management and reporting

  • Strategic planning and budgeting

  • Operational efficiency and cost optimization

  • Healthcare industry regulations and compliance

  • Leadership and team development


Professional Impact


During his tenure as Vice President - Finance / Chief Financial Officer, Marc has played a pivotal role in enhancing Ellis Medicine's financial performance and operational effectiveness. He has implemented robust financial controls, streamlined processes, and developed innovative strategies to drive cost savings and revenue growth. His strategic leadership and collaborative approach have been instrumental in supporting the organization's mission and positioning it for long-term success.

Conclusion


With his extensive experience in finance, a proven track record of success, and a deep understanding of the healthcare industry, Marc Mesick is a valuable asset to Ellis Medicine. As he continues to guide the organization's financial strategy and contribute to its overall growth and development, he remains committed to driving sustainable, data-driven decisions that enhance patient care and organizational performance.